Acousia Therapeutics
Phase 2Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany, dedicated to identify small molecules for an innovative treatment of hearing loss.
Founded
2012
Focus
Small Molecules
About
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany, dedicated to identify small molecules for an innovative treatment of hearing loss.
Funding History
3Total raised: $95M
Grant$10MGerman Federal Ministry of Education and ResearchMar 15, 2022
Series B$60MBioMedPartnersSep 15, 2021
Series A$25MBioMedPartnersJun 15, 2018
Company Info
TypePrivate
Founded2012
LocationTübingen, Germany
StagePhase 2
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile